Governance Strategies in Biomedical Innovation
Author Information
Author(s): Brian Salter, Alex Faulkner
Primary Institution: King's College London
Hypothesis
How can governance strategies in biomedical innovation be aligned to better understand the role of 'Rising Powers' in the global context?
Conclusion
An integrative conceptual framework is needed to understand the co-production of innovation and governance in the biomedical sector.
Supporting Evidence
- Biomedical innovation is a global priority for many countries.
- Rising Powers like China and India are challenging the traditional dominance of the US in biomedical innovation.
- Governance strategies must adapt to the complexities of innovation processes.
Takeaway
Countries are trying to figure out how to work together to create new medical technologies while also making sure everyone benefits. It's like building a big team to solve a puzzle.
Methodology
The paper reviews various social science approaches to governance in biomedical innovation, focusing on the roles of different states, particularly 'Rising Powers'.
Potential Biases
Potential bias in the selection of literature and approaches discussed.
Limitations
The paper does not provide empirical data to support its claims.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website